发布求助
文献互助 智能选刊 最新文献

InFo Neurologie + Psychiatrie最新文献

筛选
英文 中文
Weiteres Argument für antikatabole Diät bei ALS 支持抗代谢饮食治疗 ALS 的另一个论点
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3964-1
Albert C. Ludolph
{"title":"Weiteres Argument für antikatabole Diät bei ALS","authors":"Albert C. Ludolph","doi":"10.1007/s15005-024-3964-1","DOIUrl":"https://doi.org/10.1007/s15005-024-3964-1","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"11 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141137719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wie lange soll die Erhaltungstherapie mit Temozolomid fortgeführt werden? 替莫唑胺的维持治疗应持续多久？
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3962-3
Michael Weller
{"title":"Wie lange soll die Erhaltungstherapie mit Temozolomid fortgeführt werden?","authors":"Michael Weller","doi":"10.1007/s15005-024-3962-3","DOIUrl":"https://doi.org/10.1007/s15005-024-3962-3","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"56 s65","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Was bringt die allogene Stammzelltherapie? 异体干细胞疗法有什么好处？
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3956-1
Hans-Christoph Diener
{"title":"Was bringt die allogene Stammzelltherapie?","authors":"Hans-Christoph Diener","doi":"10.1007/s15005-024-3956-1","DOIUrl":"https://doi.org/10.1007/s15005-024-3956-1","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"3 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141138226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D verhindert nicht die Entstehung einer MS nach erstem klinischen Ereignis 维生素 D 不能预防首次临床事件后多发性硬化症的发展
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3961-4
T. Menge
{"title":"Vitamin D verhindert nicht die Entstehung einer MS nach erstem klinischen Ereignis","authors":"T. Menge","doi":"10.1007/s15005-024-3961-4","DOIUrl":"https://doi.org/10.1007/s15005-024-3961-4","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"127 s442","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141134623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depot-Antipsychotika auch wirksam in akuten Phasen 非处方抗精神病药物在急性期也有效
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3971-2
Alkomiet Hasan
{"title":"Depot-Antipsychotika auch wirksam in akuten Phasen","authors":"Alkomiet Hasan","doi":"10.1007/s15005-024-3971-2","DOIUrl":"https://doi.org/10.1007/s15005-024-3971-2","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"17 S3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141141339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klinische Faktoren für den Behandlungsverlauf nach SHT 创伤性脑损伤后疗程的临床因素
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3963-2
F. Salih
{"title":"Klinische Faktoren für den Behandlungsverlauf nach SHT","authors":"F. Salih","doi":"10.1007/s15005-024-3963-2","DOIUrl":"https://doi.org/10.1007/s15005-024-3963-2","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"26 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141136634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welche Therapieansätze gibt es bei der amyotrophen Lateralsklerose? 肌萎缩侧索硬化症有哪些治疗方法？
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3938-3
Albert C. Ludolph, C. Lang
{"title":"Welche Therapieansätze gibt es bei der amyotrophen Lateralsklerose?","authors":"Albert C. Ludolph, C. Lang","doi":"10.1007/s15005-024-3938-3","DOIUrl":"https://doi.org/10.1007/s15005-024-3938-3","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":" 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141131142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sind Botox-Injektionen wirksam? 肉毒杆菌毒素注射有效吗？
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3907-x
G. Deuschl
{"title":"Sind Botox-Injektionen wirksam?","authors":"G. Deuschl","doi":"10.1007/s15005-024-3907-x","DOIUrl":"https://doi.org/10.1007/s15005-024-3907-x","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"31 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141137348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Begleitende depressive Symptome bei Migräne werden gebessert 偏头痛的伴随抑郁症状得到改善
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3959-y
Hans-Christoph Diener
{"title":"Begleitende depressive Symptome bei Migräne werden gebessert","authors":"Hans-Christoph Diener","doi":"10.1007/s15005-024-3959-y","DOIUrl":"https://doi.org/10.1007/s15005-024-3959-y","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":"350 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141143802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Umstellung von intravenösen auf subkutane Immunglobuline 从静脉注射免疫球蛋白转为皮下注射免疫球蛋白
InFo Neurologie + Psychiatrie Pub Date : 2024-05-01 DOI: 10.1007/s15005-024-3949-0
G. Springer
{"title":"Umstellung von intravenösen auf subkutane Immunglobuline","authors":"G. Springer","doi":"10.1007/s15005-024-3949-0","DOIUrl":"https://doi.org/10.1007/s15005-024-3949-0","url":null,"abstract":"","PeriodicalId":13736,"journal":{"name":"InFo Neurologie + Psychiatrie","volume":" 21","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141131454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信